What Caused The Unicycive (UNCY) Stock To Rise On Tuesday?
At last check, Unicicive Therapeutics Inc. (NASDAQ: UNCY) shares were up 9.43% to $0.58 in the current market. The surge in the stock of the clinical-stage biotechnology company came on the heels of a licensing agreement with a major pharmaceutical company in Asia. UNCY has announced which agreement? With Lotus Pharmaceutical, a top-tier international pharmaceutical […]